Revolutionizing Clinical Trials: A Manifesto for AI-Driven Transformation
This addresses the problem of inefficient clinical trials for patients and pharmaceutical industries, but it is incremental as it focuses on integration within existing frameworks.
The manifesto tackles the challenge of improving clinical trials by proposing a roadmap for integrating AI technologies like causal inference and digital twins, aiming to deliver faster, safer, and more personalized patient outcomes.
This manifesto represents a collaborative vision forged by leaders in pharmaceuticals, consulting firms, clinical research, and AI. It outlines a roadmap for two AI technologies - causal inference and digital twins - to transform clinical trials, delivering faster, safer, and more personalized outcomes for patients. By focusing on actionable integration within existing regulatory frameworks, we propose a way forward to revolutionize clinical research and redefine the gold standard for clinical trials using AI.